Search for: "Amylin Pharmaceuticals, Inc."
Results 21 - 40
of 51
Sort by Relevance
|
Sort by Date
9 Nov 2009, 5:34 pm
Byetta is manufactured by San Diego-based Amylin Pharmaceuticals Inc. [read post]
6 Nov 2009, 8:14 am
Byetta, made by Amylin Pharmaceuticals Inc. of San Diego, is used to control blood sugar levels in Type II diabetes patients already using diet, exercise and some other diabetes medications. [read post]
5 Nov 2009, 7:20 pm
The FDA reported Byetta (exenatide), a drug manufactured by Amylin Pharmaceuticals, Inc. and Eli Lilly and Company, prescribed to treat type 2 diabetes may pose serious kidney problems to patients. [read post]
5 Nov 2009, 1:12 pm
Despite numerous claims of patients diagnosed with pancreatitis who have taken Byetta, including several deaths, neither the FDA or the drug manufacturer, Amylin Pharmaceuticals, have announced plans to issue a Byetta recall. [read post]
4 Nov 2009, 2:03 am
Food and Drug Administration has issued a warning about possible kidney problems associated with the use of Byetta, a diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. [read post]
4 Nov 2009, 2:03 am
Food and Drug Administration has issued a warning about possible kidney problems associated with the use of Byetta, a diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. [read post]
3 Nov 2009, 2:35 pm
On November 2, 2009 Amylin Pharmaceuticals, Inc., and Eli Lilly and Company issued their joint statement in response to the FDA on BYETTA® (exenatide) injection. [read post]
3 Nov 2009, 11:00 am
Byetta is manufactured by San Diego-based Amylin Pharmaceuticals Inc [read post]
2 Nov 2009, 11:04 pm
Amylin Pharmaceuticals Inc. and Eli Lilly & Co. said safety warnings were strengthened for their diabetes drug Byetta relating to the risks of pancreatitis and the medicine's use by patients with severe kidney disease. [read post]
25 Sep 2009, 2:09 pm
.'s diabetes treatment Januvia/Sitagliptin and occurrences of acute pancreatitis, the same issue that sunk sales of Amylin Pharmaceuticals Inc.'s Byetta.From the FDA site:FDA notified healthcare professionals and patients of revisions to the prescribing information for Januvia (sitagliptin) and Janumet (sitagliptin/metformin) to include information on reported cases of acute pancreatitis in patients using these products. [read post]
26 May 2009, 6:27 am
Amylin Pharmaceuticals, Inc. arose out of a proxy contest in which two separate dissident stockholders [1] of Amylin, prevented from agreeing to form a unified minority slate by the Company's "poison pill," each proposed a slate of five nominees to the 12-member Amylin Board of Directors, thereby raising the possibility that a majority of the Board could be changed at the upcoming Annual Meeting despite each stockholder's seeking only… [read post]
12 May 2009, 4:21 pm
Amylin Pharmaceuticals, Inc., No. 4446-VCL (Del.Ch., May 12, 2009), read opinion here. [read post]
12 May 2009, 3:43 pm
In 2007 Amylin Pharmaceuticals issued 3.00% convertible senior notes due 2014. [read post]
12 May 2009, 9:32 am
Amylin Pharmaceuticals Inc., C.A. 4446-VCL (May 12, 2009) One defense against a hostile takeover is a provision that permits only "continuing directors" to approve certain important corporate acts. [read post]
19 Apr 2009, 12:37 pm
This is currently the case with Amylin Pharmaceuticals, Inc., which has received notices of nominations of short slates from both Eastbourne Capital Management L.L.C. and funds affiliated with Carl Icahn. [read post]
16 Mar 2009, 11:20 am
The report points out that this new analysis was funded by Amylin Pharmaceuticals Inc., the drug company that makes Byetta, and Eli Lilly & Co., which is Amylin's marketing partner for Byetta sales in the U.S. [read post]
5 Mar 2009, 10:22 am
Byetta is a diabetes drug co-marketed in the U.S. by Amylin Pharmaceuticals Inc., based in San Diego, and Eli Lilly & Co., of Indianapolis. [read post]
2 Nov 2008, 3:38 pm
FDA is working with the maker of Byetta, Amylin Pharmaceuticals, Inc., to add stronger and more prominent warnings in the product label about the risk of acute hemorrhagic or necrotizing pancreatitis. [read post]
16 Oct 2008, 8:19 pm
We had previously written a blog about Byetta developed by Eli Lilly and Company and Amylin Pharmaceuticals, Inc. [read post]
13 Sep 2008, 1:09 pm
FDA is working with the maker of Byetta, Amylin Pharmaceuticals, Inc., to add stronger and more prominent warnings in the product label about the risk of acute hemorrhagic or necrotizing pancreatitis If you believe you have a case and have sustained injuries from taking Byetta, first, do not stop taking your medication. [read post]
